Amarin Corp Plc (AMRN)

[HDGabor]

P-

Lovaza > Vascepa imo for the above, and other, reasons. That's why it remains tier 1 on all plans. Including the largest plan in the country. While that same plan has Vas as tier 3.

First of all: I stand corrected since isn't living in the US ... but OMG
- show me any plan that keep Lovaza as Tier 1 (I guess it wasn't Tier 1 ever)
- if you mean generic Lovaza (as I think ...)
a.) I am sure it isn't Tier 1 in all plan
b.) you have to know that generic and brand products tiered differently. If the brand is still exist - meanwhile generic is available - the generic has a better tier than brand.

despite a legal disclaimer saying they cannot be held to everything written in it (obviously)

Why is it obvious?

FDA has openly stated ARR and RRR must be presented together on labeling.

Please cite. It was a recommendation (by the authors and not by the FDA) and wasn't a must. Furthermore you forget to cite any publication with ARR only (without RRR), meanwhile RRR (without ARR) are exist ...

When management says they "estimate" the mean TG will be "above 200," but not "above 220," or "250," etc., I assume they mean pretty close to 200. That means many patients must have enrolled with TG counts from 150 - 199. And then they also say just one other risk factor is needed. That can be elevated LDL-C. This is me just quoting them.

No surprise ... You see something and failed to check ... Furthermore I provided the exact details with exact references
a.) TG - read the AdCom slides, the Co stated de facto the TG levels for the first 6,075 patients (inc. breakdown of the app. 5,000-6,075) and it was 220.
b.) LDL-C inclusion criteria: 40-100 ... it isn't listed among risk factors

Nothing is "perfectly." My point is they are all advised

Please check study location and try to think out of the bubble ...

Interesting they say "similar." Relative to dose, perhaps.

You forget the previous sentence ... "a comparison of EPA blood levels in relevant trials suggest that 4 g doses of EPA provide similar EPA blood levels in the Western population studied when compared to the post-1.8g EPA-dose Japanese population studied in JELIS."

over 60% of the baseline levels of the JELIS study.

Previously you said: the same ...

If you compare JELIS with MARINE baseline (which may be closer to R-IT baseline)

What? IS MARINE closer to R-IT than ANCHOR? Are you serious?

I said it wasn't sponsored by AMRN, according to AMRN. I also believe that.

What is about chemtrail? .... UMIN000002815

Best,
G

ps.: I will explain / detail later (tom.) the 75% approach